Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13.77% | 144.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.77% | -44.68% | |||
| Cost of Revenue | -76.63% | 36.10% | |||
| Gross Profit | 352.72% | -139.34% | |||
| SG&A Expenses | -33.78% | 23.04% | |||
| Depreciation & Amortization | -20.99% | -4.56% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -31.94% | 18.06% | |||
| Operating Income | 32.66% | -20.22% | |||
| Income Before Tax | 31.46% | 65.14% | |||
| Income Tax Expenses | 3,740.00% | 100.11% | |||
| Earnings from Continuing Operations | 31.25% | 64.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.25% | 64.50% | |||
| EBIT | 32.66% | -20.22% | |||
| EBITDA | 33.00% | -21.11% | |||
| EPS Basic | 64.05% | 70.32% | |||
| Normalized Basic EPS | 64.62% | -4.36% | |||
| EPS Diluted | 64.04% | 70.29% | |||
| Normalized Diluted EPS | 64.62% | -4.36% | |||
| Average Basic Shares Outstanding | 91.26% | 19.63% | |||
| Average Diluted Shares Outstanding | 91.26% | 19.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||